Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
272 |
|
| Actual shortage: | 6 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 14 (5%) | |
| Resolved: | 251 (92%) | |
Discontinuation Reports |
49 |
|
| To be discontinued: | 5 (10%) | |
| Discontinued: | 44 (90%) | |
| Reversed: | 0 (0%) | |
Late reports |
20 (6%) |
|
Overdue reports |
4 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYOCHRYSINE | 50MG | SOLUTION | Resolved | 2017-11-15 | 2019-06-10 | 29274 |
| MYOCHRYSINE | 25MG | SOLUTION | Resolved | 2017-11-15 | 2019-06-10 | 29269 |
| MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2017-07-06 | 2017-08-04 | 14864 |
| MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2018-02-09 | 2018-03-05 | 39185 |
| MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2018-04-10 | 2019-06-10 | 45370 |
| MULTAQ | 400MG | TABLET | Resolved | 2018-12-10 | 2019-02-06 | 68993 |
| MULTAQ | 400MG | TABLET | Resolved | 2021-07-23 | 2021-11-17 | 142946 |
| MULTAQ | 400MG | TABLET | Resolved | 2024-03-13 | 2024-04-19 | 222061 |
| MOZOBIL | 20MG | SOLUTION | Resolved | 2020-06-19 | 2020-06-26 | 118345 |
| MOZOBIL | 20MG | SOLUTION | Avoided shortage | 2020-09-25 | 2020-11-25 | 125088 |
| MERSYNDOL WITH CODEINE | 5MG 8MG 325MG | TABLET | Resolved | 2022-05-02 | 2022-05-02 | 159874 |
| MERSYNDOL WITH CODEINE | 5MG 8MG 325MG | TABLET | Resolved | 2022-05-03 | 2022-05-17 | 159914 |
| MERSYNDOL WITH CODEINE | 5MG 8MG 325MG | TABLET | Resolved | 2022-07-13 | 2022-08-06 | 164562 |
| MERSYNDOL WITH CODEINE | 5MG 8MG 325MG | TABLET | Resolved | 2022-10-28 | 2022-11-30 | 173080 |
| MERSYNDOL WITH CODEINE | 325MG 5MG 8MG | TABLET | Resolved | 2023-05-05 | 2023-07-10 | 191773 |
| LOVENOX WITH PRESERVATIVE 300MG/3ML | 100MG | SOLUTION | Resolved | 2020-02-21 | 2020-03-03 | 106822 |
| LOVENOX WITH PRESERVATIVE 300MG/3ML | 100MG | SOLUTION | Resolved | 2020-03-12 | 2020-04-22 | 108530 |
| LOVENOX WITH PRESERVATIVE 300MG/3ML | 100MG | SOLUTION | Avoided shortage | 2021-05-03 | 2021-12-02 | 138654 |
| LOVENOX WITH PRESERVATIVE 300MG/3ML | 100MG | SOLUTION | Resolved | 2023-02-10 | 2023-05-12 | 184402 |
| LOVENOX HP | 120MG | SOLUTION | Resolved | 2017-03-14 | 2017-03-29 | 2476 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
| KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
| JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
| IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
| FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
| FLAGYL | 10% | CREAM | To be discontinued | 2024-03-28 | 2024-03-28 | 223877 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
| DIABETA | 2.5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100935 |
| DIABETA | 5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100938 |
| DEMEROL | 50MG | TABLET | Discontinued | 2019-11-11 | 2020-07-29 | 98380 |
| CONDYLINE | 0.5% | SOLUTION | To be discontinued | 2021-07-13 | 2021-07-13 | 142368 |
| CLOMID | 50MG | TABLET | Discontinued | 2017-03-22 | 2017-03-22 | 3917 |
| CLAFORAN - PWS INJ 2.0G/VIAL | 2G | POWDER FOR SOLUTION | Discontinued | 2017-03-20 | 2017-04-05 | 3685 |
| CLAFORAN - PWS INJ 1.0G/VIAL | 1G | POWDER FOR SOLUTION | Discontinued | 2017-03-16 | 2017-05-02 | 3103 |